Publications by authors named "Y Meyer"

Article Synopsis
  • Long-COVID patients showed reduced physical fitness, and a study aimed to assess how pulmonary rehabilitation (PR) impacts their fitness, quality of life (QoL), and CT scan results.
  • A 3-month PR program involved endurance and resistance training, with assessments indicating significant improvements in patient-reported outcomes and test results like the six-minute walk test (6MWT) and peak exercise load.
  • The study found that PR helped restore lung capacity and airway volume while improving QoL, suggesting that rehabilitation is beneficial for long-COVID patients.
View Article and Find Full Text PDF

Liver is the third most common organ for breast cancer (BC) metastasis. Two main histopathological growth patterns (HGP) exist in liver metastases (LM): desmoplastic and replacement. Although a reduced immunotherapy efficacy is reported in patients with LM, tumor-infiltrating lymphocytes (TIL) have not yet been investigated in BCLM.

View Article and Find Full Text PDF

Background: Guidelines are inconclusive on whether contrast-enhanced MRI using gadoxetic acid and diffusion-weighted imaging should be added routinely to CT in the investigation of patients with colorectal liver metastases who are scheduled for curative liver resection or thermal ablation, or both. Although contrast-enhanced MRI is reportedly superior than contrast-enhanced CT in the detection and characterisation of colorectal liver metastases, its effect on clinical patient management is unknown. We aimed to assess the clinical effect of an additional liver contrast-enhanced MRI on local treatment plan in patients with colorectal liver metastases amenable to local treatment, based on contrast-enhanced CT.

View Article and Find Full Text PDF

Background: Maintaining a sufficient health-related quality of life (HRQoL) is important in the palliative treatment of patients with metastatic colorectal cancer (mCRC). The ORCHESTRA trial (ClinicalTrials.gov identifier: NCT01792934) is designed to prospectively evaluate overall survival benefit and impact on HRQoL of tumor debulking when added to first-line palliative systemic therapy in patients with multiorgan mCRC.

View Article and Find Full Text PDF